Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
DAPT (GSI-IX): Notch Signaling Evidence Guide
2026-10-08
DAPT, also called GSI-IX, is a γ-secretase inhibitor used to study amyloid precursor protein processing and Notch signaling. Peer-reviewed evidence supports Notch inhibition as a context-dependent tool for examining thymic epithelial cell differentiation, while vendor potency values require assay-specific interpretation.
-
Shrimp STING and the Evolution of DNA Sensing
2026-10-08
A 2024 Journal of Immunology study identifies shrimp STING as a direct sensor of double-stranded DNA as well as cyclic dinucleotides, extending current models of innate immune signaling beyond the canonical mammalian cGAS–STING framework. The findings support a shrimp DNA–STING–IKKε–IRF–Vago antiviral axis, while leaving important questions about receptor specificity, pathway conservation, and broader invertebrate applicability.
-
How Nitric Oxide Improves Tumour Nanoparticle Delivery
2026-10-07
A 2025 Nature Biomedical Engineering study identifies the tumour vascular basement membrane as a major, previously underappreciated barrier to nanoparticle extravasation. Its nitric oxide nanogenerator transiently opens endothelial junctions and locally disrupts the basement membrane, improving nanoparticle delivery and tumour suppression in mouse and rabbit models while highlighting the need to control degradation-related safety risks.
-
From Reporter mRNA to Translational Insight
2026-10-07
Dual-reporter mRNA can connect cargo delivery, intracellular localization, translation, and biological response in one conceptual measurement framework. This article examines how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) may support translational research while distinguishing product attributes from evidence generated in therapeutic mRNA nanoparticle studies.
-
Amt-1, Nrf2/HO-1, and Influenza A Defense
2026-10-06
The reference study presents Amt-1 as an adamantane derivative with a dual antiviral and host-directed profile against influenza A virus. Its evidence connects residual M2 ion-channel interaction with Nrf2/HO-1 activation, reduced inflammatory signaling, lower lung viral burden, and improved outcomes in a mouse model, while leaving important translational questions unresolved.
-
Dextrose and D-Glucose in Tumor Immunometabolism
2026-10-06
Dextrose, or D-glucose, is a central metabolic substrate in research on glycolysis, cellular energy production, and tumor–immune interactions. This overview examines how glucose availability is framed in hypoxic tumor microenvironments, what the current review evidence supports, and where conclusions remain limited by model complexity, study design, and clinical applicability.
-
Aprotinin and the Translational Protease Lens
2026-10-05
A mechanistic and translational perspective on Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI), linking reversible serine protease control with fibrinolysis research, cardiovascular blood management, and carefully bounded applications in protease-aware transcriptomics.
-
BCA Protein Quantification Kit K4102 Overview
2026-10-05
A concise, source-limited overview of APExBIO’s K4102 Bicinchoninic Acid Assay for research protein quantification, with no matched paper evidence.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody: Evidence Lens
2026-10-04
Explore how the FITC Goat Anti-Mouse IgG (H+L) Antibody supports interpretation of antiviral immunofluorescence and flow cytometry data. This article connects secondary-antibody signal biology with the Amt-1 influenza study while emphasizing evidence strength, assay boundaries, and translational relevance.
-
Cy5 Maleimide in Condensate Biology
2026-10-03
A charge-aware perspective on using cysteine-selective Cy5 probes to study α-synuclein condensates, molecular partitioning, and translational biomarker questions.
-
Cy5 amine (non-sulfonated) Labeling Protocol
2026-10-02
Cy5 amine (non-sulfonated), SKU A8143, provides a primary amino group for covalent attachment to compatible activated esters, activated carboxyl groups, or epoxides while supplying a near-red fluorescent readout. It is insoluble in water, so it should be dissolved in DMSO or ethanol before controlled transfer into an aqueous labeling workflow; it is not intended for diagnostic or medical use.
-
Dihydroquercetin and Wnt/β-Catenin in Porcine Cells
2026-10-01
The reference study shows that dihydroquercetin (DHQ, taxifolin) promotes IPEC-J2 porcine intestinal epithelial cell proliferation while increasing tight-junction and proliferation-associated markers through Wnt/β-catenin signaling. Its inhibitor-based design connects a flavonoid treatment to a defined signaling mechanism, although the findings remain primarily an in vitro cell-model result.
-
Cy5 maleimide (non-sulfonated): Practical Guide
2026-10-01
Cy5 maleimide (non-sulfonated) is a thiol-reactive labeling reagent for attaching a far-red fluorophore to cysteine-containing peptides and proteins through stable thioether bonds. It is appropriate for workflows that can manage low aqueous solubility and accessible thiols, but it is not a good choice when the target lacks reactive cysteines or direct dissolution in water is required.
-
Protease Inhibitor Cocktail for OXPHOS Assays
2026-09-30
Learn how the Protease Inhibitor Cocktail preserves protein integrity in OXPHOS cancer workflows. This evidence-aware guide connects LRPPRC–dasatinib biology with practical extraction, assay selection, and EDTA-free sample handling.
-
Ruxolitinib Phosphate: From JAK1/2 to Tumor Fate
2026-09-30
Ruxolitinib phosphate (INCB018424) offers translational researchers a precise way to connect JAK1/JAK2 inhibition with mitochondrial dynamics, apoptosis, and pyroptosis while preserving relevance to inflammatory and autoimmune disease models.